| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0084 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0071 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0026 | 1 |